Search Results - "Marr, Kieren A"

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America by Pappas, Peter G, Kauffman, Carol A, Andes, David R, Clancy, Cornelius J, Marr, Kieren A, Ostrosky-Zeichner, Luis, Reboli, Annette C, Schuster, Mindy G, Vazquez, Jose A, Walsh, Thomas J, Zaoutis, Theoklis E, Sobel, Jack D

“…It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment…”
Get full text

Aspergillosis Complicating Severe Coronavirus Disease by Marr, Kieren A, Platt, Andrew, Tornheim, Jeffrey A, Zhang, Sean X, Datta, Kausik, Cardozo, Celia, Garcia-Vidal, Carolina

“…Aspergillosis complicating severe influenza infection has been increasingly detected worldwide. Recently, coronavirus disease-associated pulmonary…”
Get full text

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America by Patterson, Thomas F, Thompson, 3rd, George R, Denning, David W, Fishman, Jay A, Hadley, Susan, Herbrecht, Raoul, Kontoyiannis, Dimitrios P, Marr, Kieren A, Morrison, Vicki A, Nguyen, M Hong, Segal, Brahm H, Steinbach, William J, Stevens, David A, Walsh, Thomas J, Wingard, John R, Young, Jo-Anne H, Bennett, John E

“…It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment…”
Get full text

Coronavirus Disease 2019–Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients by Permpalung, Nitipong, Chiang, Teresa Po-Yu, Massie, Allan B, Zhang, Sean X, Avery, Robin K, Nematollahi, Saman, Ostrander, Darin, Segev, Dorry L, Marr, Kieren A

“…Abstract Background Coronavirus disease 2019 (COVID-19)–associated pulmonary aspergillosis (CAPA) occurs in critically ill patients with COVID-19. Risks and…”
Get full text

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial by Maertens, Johan A, Prof, Raad, Issam I, Prof, Marr, Kieren A, Prof, Patterson, Thomas F, Prof, Kontoyiannis, Dimitrios P, Prof, Cornely, Oliver A, Prof, Bow, Eric J, Prof, Rahav, Galia, Prof, Neofytos, Dionysios, MD, Aoun, Mickael, MD, Baddley, John W, Prof, Giladi, Michael, MD, Heinz, Werner J, MD, Herbrecht, Raoul, Prof, Hope, William, Prof, Karthaus, Meinolf, Prof, Lee, Dong-Gun, Prof, Lortholary, Olivier, Prof, Morrison, Vicki A, Prof, Oren, Ilana, MD, Selleslag, Dominik, MD, Shoham, Shmuel, MD, Thompson, George R, MD, Lee, Misun, PhD, Maher, Rochelle M, MS, Schmitt-Hoffmann, Anne-Hortense, PhD, Zeiher, Bernhardt, MD, Ullmann, Andrew J, Prof

“…Summary Background Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The SECURE trial assessed efficacy and safety of isavuconazole…”
Get full text

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America by Patterson, Thomas F, Thompson, 3rd, George R, Denning, David W, Fishman, Jay A, Hadley, Susan, Herbrecht, Raoul, Kontoyiannis, Dimitrios P, Marr, Kieren A, Morrison, Vicki A, Nguyen, M Hong, Segal, Brahm H, Steinbach, William J, Stevens, David A, Walsh, Thomas J, Wingard, John R, Young, Jo-Anne H, Bennett, John E

“…It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment…”
Get full text

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET) by Pappas, Peter G., Alexander, Barbara D., Andes, David R., Hadley, Susan, Kauffman, Carol A., Freifeld, Alison, Anaissie, Elias J., Brumble, Lisa M., Herwaldt, Loreen, Ito, James, Kontoyiannis, Dimitrios P., Lyon, G. Marshall, Marr, Kieren A., Morrison, Vicki A., Park, Benjamin J., Patterson, Thomas F., Perl, Trish M., Oster, Robert A., Schuster, Mindy G., Walker, Randall, Walsh, Thomas J., Wannemuehler, Kathleen A., Chiller, Tom M.

“…Background. Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among organ transplant recipients. Multicenter prospective…”
Get full text

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry by Horn, David L., Neofytos, Dionissios, Anaissie, Elias J., Fishman, Jay A., Steinbach, William J., Olyaei, Ali J., Marr, Kieren A., Pfaller, Michael A., Chang, Chi-Hsing, Webster, Karen M.

“…Background. Candidemia remains a major cause of morbidity and mortality in the health care setting, and the epidemiology of Candida infection is changing…”
Get full text

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation by Gooley, Ted A, Chien, Jason W, Pergam, Steven A, Hingorani, Sangeeta, Sorror, Mohamed L, Boeckh, Michael, Martin, Paul J, Sandmaier, Brenda M, Marr, Kieren A, Appelbaum, Frederick R, Storb, Rainer, McDonald, George B

“…This comparison of outcomes of allogeneic hematopoietic stem-cell transplantation in 1993–1997 and 2003–2007 shows that although patients had a somewhat poorer…”
Get full text

Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation by Garcia-Vidal, Carol, Upton, Arlo, Kirby, Katharine A., Marr, Kieren A.

“…Background. Invasive mold infections (IMIs) are common in individuals who have undergone hematopoietic stem cell transplantation (HSCT). We sought to determine…”
Get full text

Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy by Elsegeiny, Waleed, Marr, Kieren A, Williamson, Peter R

“…Cryptococcal meningoencephalitis is responsible for upwards of 15% of HIV-related deaths worldwide and is currently the most common cause of non-viral…”
Get full text

Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline by FLOWERS, Christopher R, SEIDENFELD, Jerome, RAMSEY, Scott D, BOW, Eric J, KARTEN, Clare, GLEASON, Charise, HAWLEY, Douglas K, KUDERER, Nicole M, LANGSTON, Amelia A, MARR, Kieren A, ROLSTON, Kenneth V. I

“…To provide guidelines on antimicrobial prophylaxis for adult neutropenic oncology outpatients and on selection and treatment as outpatients of those with fever…”
Get full text

An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients by LIMPER, Andrew H, KNOX, Kenneth S, MODY, Christopher H, PERFECT, John R, STEVENS, David A, SAROSI, George A, AMPEL, Neil M, BENNETT, John E, CATANZARO, Antonino, DAVIES, Scott F, DISMUKES, William E, HAGE, Chadi A, MARR, Kieren A

“…With increasing numbers of immune-compromised patients with malignancy, hematologic disease, and HIV, as well as those receiving immunosupressive drug regimens…”
Get full text

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America by Walsh, Thomas J., Anaissie, Elias J., Denning, David W., Herbrecht, Raoul, Kontoyiannis, Dimitrios P., Marr, Kieren A., Morrison, Vicki A., Segal, Brahm H, Steinbach, William J., Stevens, David A., van Burik, Jo-Anne, Wingard, John R., Patterson, Thomas F.

Get full text

Emerging Fungal Diseases by Nucci, Marcio, Marr, Kieren A.

“…The epidemiology of invasive fungal infection is evolving. Yeasts other than Candida albicans and molds other than Aspergillus fumigatus have emerged as…”
Get full text

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation by Wingard, John R., Carter, Shelly L., Walsh, Thomas J., Kurtzberg, Joanne, Small, Trudy N., Baden, Lindsey R., Gersten, Iris D., Mendizabal, Adam M., Leather, Helen L., Confer, Dennis L., Maziarz, Richard T., Stadtmauer, Edward A., Bolaños-Meade, Javier, Brown, Janice, DiPersio, John F., Boeckh, Michael, Marr, Kieren A.

“…Invasive fungal infection (IFI) is a serious threat after allogeneic hematopoietic cell transplant (HCT). This multicenter, randomized, double-blind trial…”
Get full text

Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation by Bochud, Pierre-Yves, Chien, Jason W, Marr, Kieren A, Leisenring, Wendy M, Upton, Arlo, Janer, Marta, Rodrigues, Stephanie D, Li, Sarah, Hansen, John A, Zhao, Lue Ping, Aderem, Alan, Boeckh, Michael

“…Toll-like receptors (TLRs) are a central aspect of the innate immune response. Different TLRs are associated with the immune response to different infectious…”
Get full text

Management of Cryptococcus gattii meningoencephalitis by Franco-Paredes, Carlos, Dr, Womack, Tanea, PharmD, Bohlmeyer, Teri, MD, Sellers, Brenda, BSMT, Hays, Allison, MD, Patel, Kalpesh, MD, Lizarazo, Jairo, Prof, Lockhart, Shawn R, PhD, Siddiqui, Wajid, MD, Marr, Kieren A, Prof

“…Summary Cryptococcosis is a fungal disease caused by Cryptococcus neoformans and Cryptococcus gattii . By inhalation and subsequent pulmonary infection, it may…”
Get full text

Characterizing novel olfactory receptors expressed in the murine renal cortex by Halperin Kuhns, Victoria L, Sanchez, Jason, Sarver, Dylan C, Khalil, Zoya, Rajkumar, Premraj, Marr, Kieren A, Pluznick, Jennifer L

“…The kidney uses specialized G protein-coupled receptors, including olfactory receptors (ORs), to act as sensors of molecules and metabolites. In the present…”
Get more information

Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality by Upton, Arlo, Kirby, Katharine A., Carpenter, Paul, Boeckh, Michael, Marr, Kieren A.

“…Background. Invasive aspergillosis (IA) is a leading cause of infection-related mortality following hematopoietic cell transplantation (HCT). The aim of this…”
Get full text